Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What is the Tumor Microenvironment?

Cancer Screening Considerations: Balancing the Benefits and Risks

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer History

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Symptoms

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Overview of Cell Viability and Cytotoxicity

Effects of Social and Economic Deprivation on Cancer Mortality

Metastatic Migration in Cancer may be Influenced by Metabolism

What Causes Cancer?

See more featured articles »

Transforming Cancer Care through Genomic Testing

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Classification

Secondary Lung Cancer

Insights into Oncofertility

Hot vs Cold: the differences between tumor types

Cancer Management

Cancer Glossary

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Pain Management

Cancer Epidemiology

What is Immunochemotherapy?

Cancer Diagnosis

The Biochemistry of Breast Cancer Screening

What is Tumorigenesis?

Pediatric Cancer

Cancer Pain

The Cancer Cell Surface Proteome as a Therapeutic Target

British Pioneers in Cancer Biology

Cancer Research

What Role do Biobanks Play in Cancer Research?

Assay for Monitoring and Treating Malignant Brain Tumors

CDK9 and Cancer

Is Cancer a Metabolic Disorder?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Prevention: Lowering your Risk

The Effects of Cancer on Family Life

Targeted Cancer Therapies

Acidosis and Tumor Progression

Cancer Pathophysiology

Why are Cancer Cell Lines Useful?

Caring for a Loved One with Cancer

What is Merkel Cell Carcinoma?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Cancer of Unknown Primary?

Using Biomarkers to Detect Cancer

Investigating the Molecular Mechanisms of Cancer

Living with Cancer Pain

Cancer Prognosis

Hypoxia Markers and Their Importance

Insight into Cancer Vaccines

Secondary Brain Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is Cancer?

Cutaneous Manifestations of Internal Malignancy

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Myc Mutations and Cancer

Latest Cancer News and Research

Can collagen supplements really improve your skin?

Investigating collagen peptides, this review explores their role in skin aging, assessing clinical evidence and the mechanisms behind their potential benefits.

25 Mar 2026

Systematic review identifies stress-induced biological triggers in oncology

Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic decisions, waiting for test results, fear of recurrence, and changes in daily functioning. Studies show that chronic stress can trigger biological processes that promote disease progression and weaken the body's defenses.

25 Mar 2026

iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids

iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ("Rosebud"), Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids.

From iXCells Biotechnologies 25 Mar 2026

Primerdesign partners with Origin Sciences to create novel rectal mucosal extraction workflow

Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of nucleic acid extraction and real-time PCR kits, and Origin Sciences (Origin), a company pioneering the detection and diagnosis of gastrointestinal (GI) disease through an unprecedented focus on a unique biospecimen: rectal mucus; today announced a strategic partnership to create a new protocol that optimizes DNA extraction from novel rectal mucosal samples.

From Primerdesign 25 Mar 2026

Microscopic sensors could revolutionize diagnosis and monitoring of cancer

Microscopic sensors that are as thin as a strand of hair but capable of taking multiple measurements simultaneously could revolutionize the diagnosis and monitoring of diseases like cancer.

24 Mar 2026

New approach helps immune cells find and attack solid tumors

A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine researchers.

24 Mar 2026

Online tool helps cancer patients share genetic risk with families

When a person with cancer finds out they carry an inherited genetic variant that puts them at higher risk of cancer, the results can help inform their treatment or steps to prevent additional cancer.

24 Mar 2026

Breakthrough research reshapes understanding of T cell immune responses

In a paradigm breaking study, Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM) and his team, in collaboration with Drs. Arul Chinnaiyan, S P Hicks Endowed Professor of Pathology, and Marcin Cieslik, assistant professor of pathology, both from University of Michigan Rogel Cancer Center, discovered a novel way the immune system, specifically T-cells, attack their target cells, reshaping long-held assumptions in immunology and demonstrating direct implications for the field of cancer immunology and bone marrow transplantation.

24 Mar 2026

Personalized radiotherapy reduces the risk of breast cancer recurrence

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings of a ten-year study presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona today (Wednesday).

24 Mar 2026

Polyurethane-coated implants may reduce scarring after breast reconstruction surgery

Women who are treated with mastectomy for breast cancer often choose to have surgery to reconstruct the breast using an implant.

24 Mar 2026

New nanoparticle system boosts scalable production of therapeutic exosomes

Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to produce tiny therapeutic particles released by cells, called exosomes, which are being explored as a new type of medical treatment.

24 Mar 2026

CREB5 drives stem cell-like transcriptional programs in aggressive prostate cancer

A new research paper was published in Volume 17 of Oncotarget on March 17, 2026, titled "CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer."

24 Mar 2026

Study identifies early risk factors for progressive supranuclear palsy

Progressive supranuclear palsy, or PSP, is a rare brain disease that causes problems with balance, eye movements and thinking. Civil rights leader Jesse Jackson recently passed away after living with the disease for more than a decade.

24 Mar 2026

Leadership in digital pathology with launch of next-generation Aperio GT Elite scanner and Aperio iQC software

Leica Biosystems' Aperio GT Elite scanner and iQC software streamline digital pathology workflows, ensuring high-quality results and operational efficiency.

From Leica Biosystems 24 Mar 2026

Repurposed cancer drug shows promise against drug-resistant herpes infections

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.

24 Mar 2026

Redesigned lipid nanoparticles improve mRNA delivery to lymph nodes

Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to steer the particles toward lymph nodes while reducing off-target delivery to the liver.

24 Mar 2026

BNP predicts kidney disease progression risk in diabetes patients

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, a complex physiological link in which damage to one organ can accelerate deterioration in the other.

24 Mar 2026

Study reveals genetic impact of Agent Orange on bone marrow cancers

More than 50 years after Agent Orange was used in Vietnam, a new national study published online ahead of print in Blood Advances highlights the genetic changes that link exposure to Agent Orange to myelodysplastic syndromes (MDS), a group of bone marrow cancers that can progress to acute leukemia.

23 Mar 2026

Study revises the understanding of neutrophil dynamics during respiratory viral infection

Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these cells has been a subject of debate.

23 Mar 2026

New mechanism driving glioblastoma growth offers potential treatment targets

Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma – one of the most aggressive and lethal forms of brain cancer – potentially paving the way for more effective treatments.

23 Mar 2026